Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1983 Nov;139(5):663–672.

Prolactin-Secreting Pituitary Adenomas

Mary C Martin, Eldon D Schriock, Robert B Jaffe
PMCID: PMC1010965  PMID: 6659490

Abstract

Prolactin-secreting pituitary adenoma is a common cause of gynecologic problems that include oligomenorrhea, infertility, amenorrhea and galactorrhea. Diagnosis requires a combination of endocrine testing and radiologic evaluation. The diagnosis of macroadenomas is usually straightforward and these large tumors may be associated with mass effects such as severe headache, nerve palsies or visual changes. Microadenomas may be more subtle in presentation, and the diagnosis of hyperprolactinemia without radiologic evidence of a tumor frequently is problematic. The management of prolactin-secreting adenoma remains controversial, with no clear consensus or indication for surgical versus medical treatment. Surgical intervention is a realistic option for those patients who have access to an experienced neurosurgeon and who have tumor characteristics that offer a reasonable hope for cure. Many questions remain to be answered, including the cause, natural history of development and the optimum treatment for individual cases.

Full text

PDF
663

Images in this article

664Image
on p.664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker B. L., Pierce J. G., Cornell J. S. The utility of antiserums to subunits of TSH and LH for immunochemical staining of the rat hypophysis. Am J Anat. 1972 Oct;135(2):251–267. doi: 10.1002/aja.1001350210. [DOI] [PubMed] [Google Scholar]
  2. Bansal S., Lee L. A., Woolf P. D. Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients. Am J Med. 1981 Dec;71(6):961–966. doi: 10.1016/0002-9343(81)90314-4. [DOI] [PubMed] [Google Scholar]
  3. Bergh T., Nillius S. J., Larsson S. G., Wide L. Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours. Acta Endocrinol (Copenh) 1981 Nov;98(3):333–338. doi: 10.1530/acta.0.0980333. [DOI] [PubMed] [Google Scholar]
  4. Bergh T., Nillius S. J., Wide L. Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine. Acta Endocrinol Suppl (Copenh) 1978;216:147–164. [PubMed] [Google Scholar]
  5. Bergland R. M., Torack R. M. An ultrastructural study of follicular cells in the human anterior pituitary. Am J Pathol. 1969 Nov;57(2):273–297. [PMC free article] [PubMed] [Google Scholar]
  6. Bethea C. L., Ramsdell J. S., Jaffe R. B., Wilson C. B., Weiner R. I. Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix. J Clin Endocrinol Metab. 1982 May;54(5):893–902. doi: 10.1210/jcem-54-5-893. [DOI] [PubMed] [Google Scholar]
  7. Camanni F., Genazzani A. R., Massara F., La Rosa R., Cocchi D., Müller E. E. Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects. Neuroendocrinology. 1980;30(1):2–6. doi: 10.1159/000122965. [DOI] [PubMed] [Google Scholar]
  8. Canales E. S., García I. C., Ruíz J. E., Zárate A. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil Steril. 1981 Oct;36(4):524–526. doi: 10.1016/s0015-0282(16)45806-1. [DOI] [PubMed] [Google Scholar]
  9. Carter J. N., Tyson J. E., Warne G. L., McNeilly A. S., Faiman C., Friesen H. G. Adrenocortical function in hyperprolactinemic women. J Clin Endocrinol Metab. 1977 Nov;45(5):973–980. doi: 10.1210/jcem-45-5-973. [DOI] [PubMed] [Google Scholar]
  10. Chang R. J., Keye W. R., Jr, Young J. R., Wilson C. B., Jaffe R. B. Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea. Am J Obstet Gynecol. 1977 Jun 15;128(4):356–363. doi: 10.1016/0002-9378(77)90553-1. [DOI] [PubMed] [Google Scholar]
  11. Costello R. T. Subclinical Adenoma of the Pituitary Gland. Am J Pathol. 1936 Mar;12(2):205–216.1. [PMC free article] [PubMed] [Google Scholar]
  12. Crosignani P. G., Ferrari C., Scarduelli C., Picciotti M. C., Caldara R., Malinverni A. Spontaneous and induced pregnancies in hyperprolactinemic women. Obstet Gynecol. 1981 Dec;58(6):708–713. [PubMed] [Google Scholar]
  13. Crosignani P. G., Mattei A., Ferrari C., Giovanelli M. A. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report. Br J Obstet Gynaecol. 1982 Feb;89(2):169–170. doi: 10.1111/j.1471-0528.1982.tb04688.x. [DOI] [PubMed] [Google Scholar]
  14. Del Pozo E., Varga L., Wyss H., Tolis G., Friesen H., Wenner R., Vetter L., Uettwiler A. Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes. J Clin Endocrinol Metab. 1974 Jul;39(1):18–26. doi: 10.1210/jcem-39-1-18. [DOI] [PubMed] [Google Scholar]
  15. Delitala G., Stubbs W. A., Wass J. A., Yeo T., Jones A., Williams S., Besser G. M., La Brooy S. J., Misiewicz J. J. Hypothalamic-pituitary effects of cimetidine. Lancet. 1978 Nov 11;2(8098):1054–1055. doi: 10.1016/s0140-6736(78)92384-x. [DOI] [PubMed] [Google Scholar]
  16. Domingue J. N., Wing S. D., Wilson C. B. Coexisting pituitary adenomas and partially empty sellas. J Neurosurg. 1978 Jan;48(1):23–28. doi: 10.3171/jns.1978.48.1.0023. [DOI] [PubMed] [Google Scholar]
  17. Falconer M. A., Stafford-Bell M. A. Visual failure from pituitary and parasellar tumours occurring with favourable outcome in pregnant women. J Neurol Neurosurg Psychiatry. 1975 Sep;38(9):919–930. doi: 10.1136/jnnp.38.9.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fava G. A., Fava M., Kellner R., Serafini E., Mastrogiacomo I. Depression hostility and anxiety in hyperprolactinemic amenorrhea. Psychother Psychosom. 1981;36(2):122–128. doi: 10.1159/000287535. [DOI] [PubMed] [Google Scholar]
  19. Ferrari C., Crosignani P. G., Caldara R., Picciotti M. C., Malinverni A., Barattini B., Rampini P., Telloli P. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia. J Clin Endocrinol Metab. 1980 Jan;50(1):23–26. doi: 10.1210/jcem-50-1-23. [DOI] [PubMed] [Google Scholar]
  20. Foncin J. F. Morphologie ultra-structurale de l'hypophyse humaine. Neurochirurgie. 1971 May;17(Suppl):10–24. [PubMed] [Google Scholar]
  21. Friesen H. G., Tolis G. The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study. Clin Endocrinol (Oxf) 1977;6 (Suppl):91S–99S. doi: 10.1111/j.1365-2265.1977.tb03343.x. [DOI] [PubMed] [Google Scholar]
  22. Futterweit W., Krieger D. T. Pituitary tumors associated with hyperprolactinemia and polycystic ovarian disease. Fertil Steril. 1979 Jun;31(6):608–613. doi: 10.1016/s0015-0282(16)44049-5. [DOI] [PubMed] [Google Scholar]
  23. Gemzell C., Wang C. F. Outcome of pregnancy in women with pituitary adenoma. Fertil Steril. 1979 Apr;31(4):363–372. doi: 10.1016/s0015-0282(16)43929-4. [DOI] [PubMed] [Google Scholar]
  24. Genazzani A. R., De Leo V., Murru S., Cocchi D., Camanni F., Müller E. E. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists. J Clin Endocrinol Metab. 1982 Feb;54(2):429–435. doi: 10.1210/jcem-54-2-429. [DOI] [PubMed] [Google Scholar]
  25. Goldsmith P. C., Ganong W. F. Ultrastructural localization of luteinizing hormone-releasing hormone in the median eminence of the rat. Brain Res. 1975 Oct 31;97(2):181–193. doi: 10.1016/0006-8993(75)90444-8. [DOI] [PubMed] [Google Scholar]
  26. Goldsmith P. C., Rose J. C., Arimura A., Ganong W. F. Ultrastructural localization of somatostatin in pancreatic islets of the rat. Endocrinology. 1975 Oct;97(4):1061–1064. doi: 10.1210/endo-97-4-1061. [DOI] [PubMed] [Google Scholar]
  27. Gross C. E., Binet E. F., Esguerra J. V. Metrizamide cisternography in the evaluation of pituitary adenomas and the empty sella syndrome. J Neurosurg. 1979 Apr;50(4):472–476. doi: 10.3171/jns.1979.50.4.0472. [DOI] [PubMed] [Google Scholar]
  28. Hardy J., Vezina J. L. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol. 1976;15:261–273. [PubMed] [Google Scholar]
  29. Kamoi K., Tchuchida I., Sato H., Tanaka R., Ishiguro T., Kaneko K., Iwasaki Y., Shibata A. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors. J Clin Endocrinol Metab. 1981 Dec;53(6):1285–1287. doi: 10.1210/jcem-53-6-1285. [DOI] [PubMed] [Google Scholar]
  30. Keye W. R., Jr, Chang R. J., Jaffe R. B. Prolactin secreting pituitary adenomas in women with amenorrhea or galactorrhea. Obstet Gynecol Surv. 1977 Nov;32(11):727–738. doi: 10.1097/00006254-197711000-00016. [DOI] [PubMed] [Google Scholar]
  31. Keye W. R., Jr, Chang R. J., Wilson C. B., Jaffe R. B. Prolactin-secreting pituitary adenomas. III. Frequency and diagnosis in amenorrhea-galactorrhea. JAMA. 1980 Sep 19;244(12):1329–1332. doi: 10.1001/jama.244.12.1329. [DOI] [PubMed] [Google Scholar]
  32. Keye W. R., Yuen B. H., Knopf R. F., Jaffe R. B. Amenorrhea, hyperprolactinemia and pituitary enlargement secondary to primary hypothyroidism. Successful treatment with thyroid replacement. Obstet Gynecol. 1976 Dec;48(6):697–702. [PubMed] [Google Scholar]
  33. Klibanski A., Neer R. M., Beitins I. Z., Ridgway E. C., Zervas N. T., McArthur J. W. Decreased bone density in hyperprolactinemic women. N Engl J Med. 1980 Dec 25;303(26):1511–1514. doi: 10.1056/NEJM198012253032605. [DOI] [PubMed] [Google Scholar]
  34. LEZNOFF A., FISHMAN J., GOODFRIEND L., MCGARRY E., BECK J., ROSE B. Localization of flurescent antibodies to human growth hormone in human anterior pituitary glands. Proc Soc Exp Biol Med. 1960 Jun;104:232–235. doi: 10.3181/00379727-104-25790. [DOI] [PubMed] [Google Scholar]
  35. Lachelin G. C., Abu-fadil S., Yen S. S. Functional delineation of hyperprolactinemic-amenorrhea. J Clin Endocrinol Metab. 1977 Jun;44(6):1163–1174. doi: 10.1210/jcem-44-6-1163. [DOI] [PubMed] [Google Scholar]
  36. Lamberts S. W., Seldenrath H. J., Kwa H. G., Birkenhäger J. C. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine. J Clin Endocrinol Metab. 1977 Jan;44(1):180–184. doi: 10.1210/jcem-44-1-180. [DOI] [PubMed] [Google Scholar]
  37. Landolt A. M., Keller P. J., Froesch E. R., Mueller J. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas? Lancet. 1982 Sep 18;2(8299):657–658. doi: 10.1016/s0140-6736(82)92756-8. [DOI] [PubMed] [Google Scholar]
  38. Landolt A. M. Ultrastructure of human sella tumors. Correlations of clinical findings and morphology. Acta Neurochir (Wien) 1975;Suppl 22:1–167. [PubMed] [Google Scholar]
  39. Landolt A. M., Wüthrich R., Fellmann H. Regression of pituitary prolactinoma after treatment with bromocriptine. Lancet. 1979 May 19;1(8125):1082–1083. doi: 10.1016/s0140-6736(79)92976-3. [DOI] [PubMed] [Google Scholar]
  40. Lobo R. A., Kletzky O. A., Kaptein E. M., Goebelsmann U. Prolactin modulation of dehydroepiandrosterone sulfate secretion. Am J Obstet Gynecol. 1980 Nov 15;138(6):632–636. doi: 10.1016/0002-9378(80)90079-4. [DOI] [PubMed] [Google Scholar]
  41. MARSHALL J. M., Jr Localization of adrenocorticotropic hormone by histochemical and immunochemical methods. J Exp Med. 1951 Jul 1;94(1):21–30. doi: 10.1084/jem.94.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Magyar D. M., Marshall J. R. Pituitary tumors and pregnancy. Am J Obstet Gynecol. 1978 Dec 1;132(7):739–751. doi: 10.1016/s0002-9378(78)80008-8. [DOI] [PubMed] [Google Scholar]
  43. March C. M., Kletzky O. A., Davajan V., Teal J., Weiss M., Apuzzo M. L., Marrs R. P., Mishell D. R., Jr Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol. 1981 Apr 1;139(7):835–844. doi: 10.1016/0002-9378(81)90553-6. [DOI] [PubMed] [Google Scholar]
  44. Marrs R. P., Bertolli S. J., Kletzky O. A. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma. Am J Obstet Gynecol. 1980 Nov 15;138(6):620–625. doi: 10.1016/0002-9378(80)90077-0. [DOI] [PubMed] [Google Scholar]
  45. Martin N. A., Hales M., Wilson C. B. Cerebellar metastasis from a prolactinoma during treatment with bromocriptine. J Neurosurg. 1981 Oct;55(4):615–619. doi: 10.3171/jns.1981.55.4.0615. [DOI] [PubMed] [Google Scholar]
  46. McGregor A. M., Scanlon M. F., Hall K., Cook D. B., Hall R. Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med. 1979 Feb 8;300(6):291–293. doi: 10.1056/NEJM197902083000606. [DOI] [PubMed] [Google Scholar]
  47. McLaren E. H., Keet P. C. Regression of the Forbes-Albright syndrome after pituitary apoplexy. Br Med J. 1973 Apr 28;2(5860):214–215. doi: 10.1136/bmj.2.5860.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. McNatty K. P., Sawers R. S., McNeilly A. S. A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature. 1974 Aug 23;250(5468):653–655. doi: 10.1038/250653a0. [DOI] [PubMed] [Google Scholar]
  49. Müller E. E., Genazzani A. R., Murru S. Nomifensine: diagnostic test in hyperprolactinemic states. J Clin Endocrinol Metab. 1978 Dec;47(6):1352–1357. doi: 10.1210/jcem-47-6-1352. [DOI] [PubMed] [Google Scholar]
  50. Nachtigall R. D., Monroe S. E., Wilson C. B., Jaffe R. B. Prolactin-secreting pituitary adenomas in women. VI. Absence of demonstrable adenomas in patients with altered menstrual function and abnormal sellar polytomography. Am J Obstet Gynecol. 1981 Jun 1;140(3):303–308. [PubMed] [Google Scholar]
  51. Peake G. T., McKeel D. W., Jarett L., Daughaday W. H. Ultrastructural, histologic and hormonal characterization of a prolactin-rich human pituitary tumor. J Clin Endocrinol Metab. 1969 Nov;29(11):1383–1393. doi: 10.1210/jcem-29-11-1383. [DOI] [PubMed] [Google Scholar]
  52. Pelkonen R., Nikkilä E. A., Grahne B. Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. Clin Endocrinol (Oxf) 1982 Apr;16(4):383–390. doi: 10.1111/j.1365-2265.1982.tb00731.x. [DOI] [PubMed] [Google Scholar]
  53. Pelletier G., Peillon F., Vila-Porcile E. An ultrastructural study of sites of granule extrusion in the anterior pituitary of the rat. Z Zellforsch Mikrosk Anat. 1971;115(4):501–507. doi: 10.1007/BF00335716. [DOI] [PubMed] [Google Scholar]
  54. Pontiroli A. E., Falsetti L., Voltolini A. M., Alberetto M., Pellicciotta G., de Pasqua A., Girardi A. M., Pozza G. Benserazide, a stimulator of prolactin release: a new test in the diagnosis of pituitary prolactin-secreting tumours. Acta Endocrinol (Copenh) 1981 Nov;98(3):326–332. doi: 10.1530/acta.0.0980326. [DOI] [PubMed] [Google Scholar]
  55. Quigley M. E., Judd S. J., Gilliland G. B., Yen S. S. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma. J Clin Endocrinol Metab. 1980 Jun;50(6):994–998. doi: 10.1210/jcem-50-6-994. [DOI] [PubMed] [Google Scholar]
  56. Quigley M. E., Ropert J. F., Yen S. S. Acute prolactin release triggered by feeding. J Clin Endocrinol Metab. 1981 May;52(5):1043–1045. doi: 10.1210/jcem-52-5-1043. [DOI] [PubMed] [Google Scholar]
  57. Racadot J., Olivier L., Porcile E., Droz B. Appareil de Golgi et origine des grains de sécrétion dans les cellules adénohypophysaires chez le rat. Etude radioautographique en microscopie électronique après injection de leucine tritiée. C R Acad Sci Hebd Seances Acad Sci D. 1965 Oct 11;261(15):2972–2974. [PubMed] [Google Scholar]
  58. Randall S., Laing I., Chapman A. J., Shalet S. M., Beardwell C. G., Kelly W. F., Davies D. Pregnancies in women with hyperprolactinaemia: obstetric and endocrinological management of 50 pregnancies in 37 women. Br J Obstet Gynaecol. 1982 Jan;89(1):20–23. doi: 10.1111/j.1471-0528.1982.tb04628.x. [DOI] [PubMed] [Google Scholar]
  59. Rigg L. A., Lein A., Yen S. S. Pattern of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol. 1977 Oct 15;129(4):454–456. doi: 10.1016/0002-9378(77)90594-4. [DOI] [PubMed] [Google Scholar]
  60. Robyn C., Leleux P., Vanhaelst L., Golstein J., Herlant M., Pasteels J. L. Immunohistochemical study of the human pituitary with anti-luteinizing hormone, anti-follicle stimulating hormone and anti-thyrotrophin sera. Acta Endocrinol (Copenh) 1973 Apr;72(4):625–642. doi: 10.1530/acta.0.0720625. [DOI] [PubMed] [Google Scholar]
  61. Rovit R. L., Fein J. M. Pituitary apoplexy: a review and reappraisal. J Neurosurg. 1972 Sep;37(3):280–288. doi: 10.3171/jns.1972.37.3.0280. [DOI] [PubMed] [Google Scholar]
  62. Samaan N. A., Bakdash M. M., Caderao J. B., Cangir A., Jesse R. H., Jr, Ballantyne A. J. Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin. Ann Intern Med. 1975 Dec;83(6):771–777. doi: 10.7326/0003-4819-83-6-771. [DOI] [PubMed] [Google Scholar]
  63. Schechter J. Electron microscopic studies of human pituitary tumors. II. Acidophilic adenomas. Am J Anat. 1973 Nov;138(3):387–399. doi: 10.1002/aja.1001380307. [DOI] [PubMed] [Google Scholar]
  64. Seppälä M., Ranta T., Hirvonen E. Hyperprolactinaemia and luteal insufficiency. Lancet. 1976 Jan 31;1(7953):229–230. doi: 10.1016/s0140-6736(76)91343-x. [DOI] [PubMed] [Google Scholar]
  65. Shapiro A. G. Pituitary adenoma, menstrual disturbance, hirsutism, and abnormal glucose tolerance. Fertil Steril. 1981 Feb;35(2):226–229. doi: 10.1016/s0015-0282(16)45328-8. [DOI] [PubMed] [Google Scholar]
  66. Spark R. F., Baker R., Bienfang D. C., Bergland R. Bromocriptine reduces pituitary tumor size and hypersection. Requiem for pituitary surgery? JAMA. 1982 Jan 15;247(3):311–316. [PubMed] [Google Scholar]
  67. Sternberger L. A., Hardy P. H., Jr, Cuculis J. J., Meyer H. G. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem. 1970 May;18(5):315–333. doi: 10.1177/18.5.315. [DOI] [PubMed] [Google Scholar]
  68. Stokes H., Boda J. M. Immunofluorescent localization of growth hormone and prolactin in the adenohypophysis of fetal sheep. Endocrinology. 1968 Dec;83(6):1362–1366. doi: 10.1210/endo-83-6-1362. [DOI] [PubMed] [Google Scholar]
  69. Tani E., Kawamura Y., Ametani T., Handa H., Imura H., Kato Y. Immunocytochemistry of acidophil granules of human pituitary. Arch Neurol. 1969 Jun;20(6):634–643. doi: 10.1001/archneur.1969.00480120080007. [DOI] [PubMed] [Google Scholar]
  70. Thorner M. O., Besser G. M. Bromocriptine treatment of hyperprolactinaemic hypogonadism. Acta Endocrinol Suppl (Copenh) 1978;216:131–146. [PubMed] [Google Scholar]
  71. Thorner M. O., Martin W. H., Rogol A. D., Morris J. L., Perryman R. L., Conway B. P., Howards S. S., Wolfman M. G., MacLeod R. M. Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab. 1980 Sep;51(3):438–445. doi: 10.1210/jcem-51-3-438. [DOI] [PubMed] [Google Scholar]
  72. Thorner M. O., Schran H. F., Evans W. S., Rogol A. D., Morris J. L., MacLeod R. M. A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine. J Clin Endocrinol Metab. 1980 Jun;50(6):1026–1033. doi: 10.1210/jcem-50-6-1026. [DOI] [PubMed] [Google Scholar]
  73. Van Dalen J. T., Greve E. L. Rapid deterioration of visual fields during bromocriptine-induced pregnancy in a patient with a pituitary adenoma. Br J Ophthalmol. 1977 Nov;61(11):729–733. doi: 10.1136/bjo.61.11.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Vekemans M., Delvoye P., L'Hermite M., Robyn C. Serum prolactin levels during the menstrual cycle. J Clin Endocrinol Metab. 1977 May;44(5):989–993. doi: 10.1210/jcem-44-5-989. [DOI] [PubMed] [Google Scholar]
  75. Vermeulen A., Ando S. Prolactin and adrenal androgen secretion. Clin Endocrinol (Oxf) 1978 Apr;8(4):295–303. doi: 10.1111/j.1365-2265.1978.tb02772.x. [DOI] [PubMed] [Google Scholar]
  76. Vermeulen A., Andó S., Verdonck L. Prolactinomas, testosterone-binding globulin, and androgen metabolism. J Clin Endocrinol Metab. 1982 Feb;54(2):409–412. doi: 10.1210/jcem-54-2-409. [DOI] [PubMed] [Google Scholar]
  77. Vermeulen A., Suy E., Rubens R. Effect of prolactin on plasma DHEA (s) levels. J Clin Endocrinol Metab. 1977 Jun;44(6):1222–1225. doi: 10.1210/jcem-44-6-1222. [DOI] [PubMed] [Google Scholar]
  78. Vezina J. L., Sutton T. J. Prolactin-secreting pituitary microadenomas: roentgenologic diagnosis. Am J Roentgenol Radium Ther Nucl Med. 1974 Jan;120(1):46–54. doi: 10.2214/ajr.120.1.46. [DOI] [PubMed] [Google Scholar]
  79. Weinstein D., Yarkoni S., Schenker J. G., Sahar A., Siew F. P., Ben-David M., Polishuk W. Z. Conservative management of suspected prolactin secreting pituitary adenoma during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1981 Apr;11(5):305–312. doi: 10.1016/0028-2243(81)90031-9. [DOI] [PubMed] [Google Scholar]
  80. Wolf A. S., Musch K., Lauritzen C. Hyperprolactinemia in anovulatory women. Incidence and endocrine features. J Endocrinol Invest. 1979 Jan-Mar;2(1):5–11. doi: 10.1007/BF03349269. [DOI] [PubMed] [Google Scholar]
  81. van Roon E., van der Vijver J. C., Gerretsen G., Hekster R. E., Wattendorff R. A. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy. Fertil Steril. 1981 Aug;36(2):173–177. doi: 10.1016/s0015-0282(16)45674-8. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES